Henry Schein stock holds firm after a fresh target lift

Published on 09/11/2026 at 16:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock traded at USD 87.97 on September 9, 2026, after Argus lifted its target to USD 143.00 on September 9, 2026. The shares were quoted about 30.0 percent above September 2025.

Isometrische 3D-Illustration der Lieferkette von Medizinprodukten von Produktion zu Klinik — Henry Schein US42548G1040 Wertschöpfungskette vom Hersteller über Lager bis zur Zahnarztpraxis isometrisch dargestellt, Illustration mit AI erstellt.

Henry Schein stock (ISIN US42548G1040) closed at USD 87.97 on Nasdaq on September 9, 2026, after a 1.00 percent daily loss. Argus lifted its target to USD 143.00 in commentary dated September 9, 2026, while the stock still traded about 30.0 percent above its level of September 2025.

Target and valuation

According to ad hoc news on September 11, 2026, Argus cited a current share price near USD 87.30 and raised its target price to USD 143.00 on September 9, 2026. The same note said the target shift reflected a live debate over Henry Schein's risk-reward profile as investors digest operating trends and sector conditions.

The stock's close of USD 87.97 on September 9, 2026 leaves it about 38.4 percent below the Argus target of USD 143.00. A move of that size keeps valuation central for traders even after the recent one-day pullback.

Market setup

Per the same ad hoc news report, Henry Schein's market capitalization was about USD 9.80 billion at that close. The same market snapshot put the one-year share-price change near 30.0 percent, and the company was quoted at USD 87.97 in Nasdaq trading on September 9, 2026.

For investors, the combination of a USD 9.80 billion market value and a 30.0 percent one-year gain leaves the latest target change in a clear valuation frame. The stock's recent USD 87.97 close shows that the debate is now centered more on upside distance than on momentum alone.

Company profile

Henry Schein Inc. sells solutions for healthcare professionals through a network of people and technology. The company trades on Nasdaq under HSIC and sits in health care distribution.